SK Biotek to invest up to €35m developing new plant in Dublin

SK Biotek, a South Korean-owned pharmaceutical contract development company, has received planning permission to develop a manufacturing facility in Swords, Co Dublin, that could represent an investment of up to €35m. The development would see the demolishing of part of the original production building and the construction phase at the site is expected to take between 12 and 18 months. Read more here.